明報新聞網

嘉和生物再遞表涉反向收購億騰集團上市申請

16 11 月, 2025

One Min Read

17 Views

億騰醫藥集團於去年10月合併嘉和生物（6998），而嘉和生物上周五（14 日）向聯交所遞交新一份招股書，涉及反向收購的新上市申請重難日木摩根士丹利及浦銀國際為其新上市申請的聯席保薦人。

原文: https://finance.mingpao.com/fin/instantf/20251116/1763287312314/%e5%98%89%e5%92%8c%e7%94%9f%e7%89%a9%e5%86%8d%e9%81%9e%e8%a1%a8-%e6%b6%89%e5%8f%8d%e5%90%91%e6%94%b6%e8%b3%bc%e5%84%84%e9%a8%b0%e9%9b%86%e5%9c%98%e4%b8%8a%e5%b8%82%e7%94%b3%e8%ab%8b

Last Update: 16 11 月, 2025

Written By

Other Articles

Previous

平潭发展(000592.SZ)：主营业务未发生重大变化

Next

<div>Meet the Newest Supercharged Growth Stock to Join Nvidia, Apple, Microsoft, Amazon, Alphabet, Meta, and Taiwan Semiconductor Manufacturing in the $1 Trillion Club. It’s Still a Buy Right Now, According to Certain Wall Street Analysts.</div>

Related Posts

明報新聞網

天氣｜天文台：大致多雲　日間部分時間有陽光

1 Min Read

明報新聞網

短片：西班牙葡萄牙恢復供電　停電期間火車、飛機停運

1 Min Read

明報新聞網

抽象派畫家Mark Rothko 4.4億元作品荷蘭展出　遭小孩刮花

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept